Go Technology!

First Posted 7th July 2016

I was recently shown this article about the NHS using wearable and portable health technology. That combined with my own experiences over the last few weeks has inspired me to write a different post to the one I had intended to.
The full article is well worth reading. In summary it says the NHS is about to fast track approval of cheap portable ECG device. This device can help monitor a patient’s heart in the home (or out in the garden or in a coffee shop etc…). It is hoped that this will aid the prompt detection of serious problems and potentially save lives.
As it happens I have recent experience of sort of thing being talked about in the article, so I thought I’d give a patients perspective on what it is hoped the deployment of these devices will achieve.

A flowchart showing the steps in treating an arrythmia
A flowchart showing the steps in treating an arrhythmia (click to enlarge)

Currently in the NHS the process through which problems are detected and monitored are quite cumbersome and expensive. Here’s an example. When I was experiencing arrhythmia a couple of years ago or so, I went through the following process to get them sorted (See the handy flow chart for a more pictorial representation).

When I began having the episodes I raised them at clinic. I was given advice on managing the episodes, but essentially was told that until there was some data to work from there was little that could be done. I was given increasingly long duration ECGs (between 2 to 7 days each.) to get a baseline and if we were lucky, capture something happening, but they revealed little.

I had several more arrhythmia episodes, and as we discussed them with the consultants in the Royal Brompton they became increasingly concerned that these could be a serious issue, and advised that should I experience them in future I should go to A&E as quickly as possible for medical intervention.
Each time I had an episode the arrhythmia would self terminate by the time I was at a medical centre where an ECG could be taken. This meant I was unable to collect the necessary information to progress the diagnosis. Whilst it was good that they terminated without medical intervention it left me having to roll the dice again each time it happened.
I could have been given more long duration ECGs, but this has its own difficulties.
Firstly my arrhythmia were infrequent enough that even the longest ECG couldn’t guarantee catching an episode.
Secondly I am not local to the Royal Brompton, so setting up one of these diagnostic ECGs would involve me making a long journey to have it fitted and a similarly long journey home. I would then have to return the device by post when the recording finished.
Alternatively it requires cooperation among hospitals. The Royal Brompton would engage my local hospital to perform the test and pass them the results. The current fashion for an internal market place in healthcare makes this very difficult because of the tortuous beaurocratic navigation required to make sure the money is spent out of the correct organisation’s pot of money. In the end it’s inconvenient and expensive for someone.

A variety of portable ECG recorders and the analysis Software. Gone are the days of something looking like an oversized Sony Walkman Cassette player (bottom left) with a record function!
A variety of portable ECG recorders and the analysis Software. Gone are the days of something looking like an oversized Sony Walkman Cassette player (bottom left) with a record function!

There is also a resource element. A portable ECG recorder for these sorts of tests can be found on Google starting around £1500-£2000 and that’s before buying the software and computer needed to analyse the recordings. Sure, hospitals may manage to negotiate deals with the suppliers, but they are still expensive pieces of equipment which are given to the care of notoriously careless patients and often the postal system. As a result there is invariably a waiting list (though rarely long in my experience) because the hospitals do not have many of the devices.

Eventually I got “lucky” and by “lucky”, I mean I had an arrhythmia that lasted longer than usual and was still in progress when I arrived at my local A&E. Whilst waiting to be seen I turned greyer than usual and felt like I’d just been made to run a couple of marathons on the trot. That got me seen quite quickly (Queue jumping super power – Go!) by a somewhat nervous A&E doctor (Nervous because I’m likely to have been one of the more complicated cases in his shift; possibly his career to date, depending upon how smug I’m feeling about my condition. The opportunities for things to go horribly wrong with me were significant). Fortunately the arrhythmia terminated of its own accord as he was obtaining the drug to Cardiovert me. We were both very relieved. The real score though was a nice clear ECG of what was going on in my heart at the time.

The ECG was sent to the Electrophysiologists at the Royal Brompton. Now having the data they needed they were able to schedule me for some space age heart surgery in the form of a procedure called a Cardiac Ablation (subsequently described by the surgeon who performed it as “adventurous”!).
Now all this took well over a year – possibly two or three years (I’m afraid my time line memory isn’t brilliant) – from me first raising the issue in clinic through to the Ablation procedure. That’s time where, had things gone differently I may have hit serious – even for me – medical problems, ranging from fainting or blacking out to strokes and embolisms. Arrhythmia are part and parcel of my condition, so the real issue is not so much how to stop them happening, as how do we obtain the data quickly enough to take corrective action?
This is where the article at the start of the post comes in.
You may recall that in a previous post I mentioned I had invested in an AliveCor ECG device. It’s exactly this type device that the article is talking about and recently I have had the opportunity to put mine through it’s paces. Incidentally  AliveCor is a brand name and though I use it throughout this article, I’m not sponsored by them nor have I anything to gain from using the name. It’s simply the brand I have because that was what I was shown by my consultant – there may well be other similar devices available that perform just as admirably.
In the past few weeks I have been experiencing increasingly frequent arrhythmia episodes. Much as before the episodes have tended to last only a short time, ending before I can get to a health centre of any kind.
This time however I had my own little mobile ECG recorder. Each time I had an episode I would take it out and record what was going on. Often I would also record myself when the episode finished to get a before and after view.
During this time I had been in contact with the Royal Brompton, receiving advice on managing the episodes with an intention to follow up in Clinic later in the year.
Eventually on a day I had experienced three or four episodes I rang in and spoke the Arrhythmia specialist nurse. The discussion turned to the mobile ECG recordings I had taken and proceeded something like:

“Excellent! Do you still have the recordings?“ “Yes.” “Can you email them to me? I’ll get the consultant to have a look at them.” “Of course. You’ll have them by this evening. ”

As I indicated, I then emailed them the 15 or so ECG recordings I had taken in the past couple of weeks. That was on the Friday. On Monday I had an email saying that the consultant felt I needed another ablation and would I like to go on the list for one, or would I prefer an outpatients appointment first?
In essence the AliveCor ECG compressed many months of diagnosis and testing into a few weeks.
As it happened I didn’t get to go through the full cycle of diagnosis and action. I was hospitalised by a serious arrhythmia a few days later (and will be having an ablation somewhat sooner than expected!). Even during the episode that hospitalised me the AliveCor ECG proved it’s worth to my mind. I was able to track what was happening and show it to the paramedics when they arrived, giving them more information to help make their decisions.
I have no doubt that over the last few weeks I have been using the AliveCor just the way envisioned by the NHS in the article. At a tenth of the price of a full portable ECG recorder they’re a financially attractive diagnosis tool for the health service. They can be available to gather data when needed, reducing the need to trawl through hours of data from a more traditional monitor. They can also provide reassurance, of a sort. Having the device with you makes you less worried about what’s happening – at least it does for me – and gives a feeling of empowerment and control over ones condition. I don’t have to simply endure it and get someone to help, I can take action and be involved in my own care.
They have their limitations though.
They can only capture events if the patient is aware of them to record them. If an arrhythmia occurs whilst sleeping for example it won’t be recorded, where a portable ECG would capture it.
The patient has to be able to use the device. Unlike a portable ECG recorder, which sits passively recording, the user of an AliveCor ECG must possess and be able to operate a compatible phone/tablet to activate the device, and some of those needing the device may be less confident with such technology but as generations roll on that will be less of an issue.
Perhaps the bigger issue is the limitations of what the device records. An AliveCor ECG is what is described as a ‘two lead’ ECG meaning there are two contacts on the patients skin picking up electrical signals when recording. A portable ECG recorder is likely to have more leads (often 5 or 7), collecting a more detailed set of information. One advantage the AliveCor has though is that it will take voice recordings as it takes the ECG, allowing symptoms to be described giving an extra dimension to the information that the traditional recorders lack or must obtained through pen and paper notes made by the patient.
The level of detail available on the AliveCor type devices may change as things develop. Approval by health organisations such as the NHS may well encourage companies to improve the devices as the market opens up further.
Despite the issues discussed above, I really hope the devices are approved for use, as I think they will prove a useful tool for many people dealing with heart conditions on a daily basis.

And of course, like fezzes, they are very cool…

https://m.youtube.com/watch?v=obnblNruPiU&vidve=5727&autoplay=1

Until next time,
Skwerg